PPB - Services

Complaints, Feedback and Enquiry

Safety Alerts

29th July 2022

Inoserp TM Pan-Africa Snake Antivenom – (UNDER REVIEW)

29th July 2022

Snake Venom Anti-Serum – (UNDER REVIEW)

4-Mar-2022

Public Alert: Use of Diclofenac for Pain Management

4-Mar-2022

Safety Updates and Recommendations for Health Care Professionals

19-Aug-2020

Dexamethasone in Management of COVID-19 Patients

25-Mar-2020

Information on Hydroxychloroquine and Chloroquine for COVID-19 Patients

3-Oct-2019

Recall of Sure Lubricated Condoms Dotted

2-Oct-2019

Genotoxic contaminant, N-nitrosodimethylamine (N-NDMA) Impurity, in Ranitidine products

14-Mar-2019

Press Statement: Fluoroquinole Antibiotics, Hydrochlorthiazide Products and Valsartan Containing Products

14-Jan-2019

Hydrochlorothiazide (HCTZ) Risk of Non-Melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)

14-Jan-2019

Systemic and inhaled quinolone and fluoroquinolone antibiotics

12-Jul-2018

Recall of Valsartan containing products by Denk Pharma

11-Jul-2018

Recall of some specific brands of Gentamicin injection in the Kenyan market

11-Jul-2018

Recall of specific batches of Folfes tablets, Hexon 5% disinfectant and Ventil tablets from Biodeal Laboratories Ltd

9-May-2018

Alert on Falsified Postinor

28-May-2018

Important identified signals on Artemether Lumefantrine

8-May-2018

Important identified signals on Ceftriaxone

8-May-2018

Alert on falsified Primaquine

26-Mar-2018

Recall of Gentamed injection batch no. 170603

8-Aug-2013

Suspension of registration of Hydroethyl Starch (HES) containing solutions

19-Mar-2010

Increased risk of myopathy with high doses of Simvastatin

23-Feb-2010

Prolongation of the QT interval due to Saquinavir boosted with Ritonavir

29-Jan-2010

Risk of non-cirrhotic portal hypertension in patients using Didanosine

21-Jul-2009

Public Alert on Herbal Contraceptive

21-Apr-2009

Updated recommendations concerning the interaction of Ceftriaxone and Calcium containing products